{
    "clinical_study": {
        "@rank": "50165", 
        "acronym": "NONSTOP", 
        "arm_group": [
            {
                "arm_group_label": "Antipsychotic treatment", 
                "arm_group_type": "Active Comparator", 
                "description": "Antipsychotic treatment according to common clinical practice\nDrugs: Aripiprazole, Olanzapine, Zuclopenthixol, Clotiapine, Flupentixol, Risperidone, Sulpiride, Trifluoperazine, Haloperidol, Quetiapine, Paliperidone, Chlorpromazine, Pipotiazine, Flufenazine, Periciazine, Clozapine, Pimozide, Perfenazine, Sertindole, Levomepromazine, Amisulpride, Asenapine, Tiapride, Droperidol, Ziprasidone."
            }, 
            {
                "arm_group_label": "Discontinuation antipsychotic treatment", 
                "arm_group_type": "Experimental", 
                "description": "Dose reduction of antipsychotic treatment (25% every 4 weeks)."
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to assess if patients who continue with antipsychotic treatment\n      for 12 or more months show the same risk of relapse (measured by PANSS) that patients with\n      the same medical condition who have followed a discontinuation treatment scheme based in the\n      presence of prodromes.\n\n      The candidates should accomplish the following criteria: first episode of non-affective\n      psychosis who have followed antipsychotic treatment for 12 months and who have already shown\n      remission criteria."
        }, 
        "brief_title": "Clinical Trial to Evaluate the Efficacy of Treatment vs Discontinuation in a First Episode of Non-affective Psychosis", 
        "completion_date": {
            "#text": "November 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Psychosis Nos/Other", 
        "condition_browse": {
            "mesh_term": [
                "Mental Disorders", 
                "Psychotic Disorders"
            ]
        }, 
        "detailed_description": {
            "textblock": "Randomized, open label, multicenter, phase III clinical trial. Number of subjects: 104. Age\n      range: 18 - 55 years of both sex.\n\n      Timepoints for evaluation: Every two weeks, during the first six months after initiation of\n      treatment discontinuation/continuation. Every four weeks during the remaining six months, to\n      complete a total follow-up scheme of 12 months."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Adult age from 18 to 55 years old\n\n          -  Non-affective psychosis diagnosis (schizophrenia, schizoaffective, schizophreniform\n             disorders, acute psychosis, other psychosis according to Diagnostic and Statistical\n             Manual of Mental Disorders, Fourth Edition (DSM-IV).\n\n          -  Antipsychotic treatment for 12 months since clinical stabilization. Clinical\n             stabilization is defined in case of admission by medical discharge (not including\n             voluntary discharge). In case of voluntary discharge or no admission to hospital,\n             clinical stabilization can be defined by the psychiatrist according to medical\n             history and the information provided by the family.\n\n          -  No changes in the antipsychotic doses in the last 4 months.\n\n          -  No suicide attempts in the last 12 months.\n\n          -  Patient who shows remission criteria.\n\n          -  Signed informed consent form.\n\n        Exclusion Criteria:\n\n          -  Patient who is not fluent in Spanish language\n\n          -  Patient who takes mood stabilizers (Lithium, antiepileptic drugs...)\n\n          -  Dependency on alcohol or other substances of abuse (cannabis, cocaine...)\n\n          -  History of brain injury with loss of consciousness for more than 1 hour, stroke or\n             other central nervous system disorders.\n\n          -  Intelligence testing (IQ) less than 70.\n\n          -  Suicide attempt from stabilization.\n\n          -  Pregnancy or planning to become pregnant during the study."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "55 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "104", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 3, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01765829", 
            "org_study_id": "NONSTOP"
        }, 
        "intervention": [
            {
                "arm_group_label": "Discontinuation antipsychotic treatment", 
                "description": "Dose reduction until withdrawal", 
                "intervention_name": "Discontinuation antipsychotic treatment", 
                "intervention_type": "Drug", 
                "other_name": [
                    "Aripiprazole", 
                    "Olanzapine", 
                    "Zuclopenthixol", 
                    "Clotiapine", 
                    "Flupentixol", 
                    "Risperidone", 
                    "Sulpiride", 
                    "Trifluoperazine", 
                    "Haloperidol", 
                    "Quetiapine", 
                    "Paliperidone", 
                    "Chlorpromazine", 
                    "Pipotiazine", 
                    "Flufenazine", 
                    "Periciazine", 
                    "Clozapine", 
                    "Pimozide", 
                    "Perfenazine", 
                    "Sertindole", 
                    "Levomepromazine", 
                    "Amisulpride", 
                    "Asenapine", 
                    "Tiapride", 
                    "Droperidol", 
                    "Ziprasidone"
                ]
            }, 
            {
                "arm_group_label": "Antipsychotic treatment", 
                "description": "Antipsychotic treatment is not modify during the study, it is administered according to common clinical practice", 
                "intervention_name": "Antipsychotic treatment", 
                "intervention_type": "Drug", 
                "other_name": "Antipsychotic drugs"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Chlorpromazine", 
                "Droperidol", 
                "Haloperidol", 
                "Trifluoperazine", 
                "Olanzapine", 
                "Clopenthixol", 
                "Clothiapine", 
                "Clozapine", 
                "Flupenthixol", 
                "Haloperidol decanoate", 
                "Methotrimeprazine", 
                "Perphenazine", 
                "Pimozide", 
                "Sulpiride", 
                "Antipsychotic Agents", 
                "Risperidone", 
                "Sultopride", 
                "Sertindole", 
                "Quetiapine", 
                "9-hydroxy-risperidone", 
                "Aripiprazole", 
                "Ziprasidone", 
                "Asenapine", 
                "Flupenthixol decanoate"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Non Affective Psychosis", 
            "First episode", 
            "Discontinuation scheme"
        ], 
        "lastchanged_date": "January 8, 2013", 
        "location": [
            {
                "contact": {
                    "email": "cheman45@gmail.com", 
                    "last_name": "Jos\u00e9 Mar\u00eda Mongil San Juan, MD", 
                    "phone": "0034956040209"
                }, 
                "facility": {
                    "address": {
                        "city": "Villamart\u00edn", 
                        "country": "Spain", 
                        "state": "C\u00e1diz", 
                        "zip": "11650"
                    }, 
                    "name": "Mental Health Unit Villamart\u00edn"
                }, 
                "investigator": {
                    "last_name": "Jos\u00e9 Mar\u00eda Mongil San Juan, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "eva.bravo.barba@gmail.com", 
                    "last_name": "Eva Bravo Barba, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Baza", 
                        "country": "Spain", 
                        "state": "Granada", 
                        "zip": "18800"
                    }, 
                    "name": "Mental Health Unit Baza"
                }, 
                "investigator": {
                    "last_name": "Eva Bravo Barba, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "marial.barrigon.sspa@juntadeandalucia.es", 
                    "last_name": "Mar\u00eda Luisa Barrig\u00f3n Est\u00e9vez, MD", 
                    "phone": "0034958038849"
                }, 
                "facility": {
                    "address": {
                        "city": "Motril", 
                        "country": "Spain", 
                        "state": "Granada", 
                        "zip": "18600"
                    }, 
                    "name": "Mental Health Unit Motril"
                }, 
                "investigator": {
                    "last_name": "Mar\u00eda Luisa Barrig\u00f3n Est\u00e9vez, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "fernandosarramea@hotmail.com", 
                    "last_name": "Fernando Sarramea Crespo, MD, PhD", 
                    "phone": "0034953021717"
                }, 
                "facility": {
                    "address": {
                        "city": "And\u00fajar", 
                        "country": "Spain", 
                        "state": "Ja\u00e9n", 
                        "zip": "23740"
                    }, 
                    "name": "Mental Health Unit And\u00fajar"
                }, 
                "investigator": {
                    "last_name": "Farnando Sarramea Crespo, MD, PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "migueortigosa@hotmail.com", 
                    "last_name": "Miguel Ortigosa Luque, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Martos", 
                        "country": "Spain", 
                        "state": "Ja\u00e9n", 
                        "zip": "23600"
                    }, 
                    "name": "Mental Health Unit Martos"
                }, 
                "investigator": {
                    "last_name": "Miguel Ortigosa Luque, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "zamarroluisa@yahoo.es", 
                    "last_name": "Mar\u00eda Luisa Zamarro Arraz, MD, PhD", 
                    "phone": "0034916530108"
                }, 
                "facility": {
                    "address": {
                        "city": "Alcobendas", 
                        "country": "Spain", 
                        "state": "Madrid", 
                        "zip": "28100"
                    }, 
                    "name": "Mental Health Unit Miraflores"
                }, 
                "investigator": {
                    "last_name": "Mar\u00eda Luisa Zamarro Arraz, MD, PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "rosagutierrez@psiquiatra.e.telefonica.net", 
                    "last_name": "Mar\u00eda Rosario Guti\u00e9rrez Labrador, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "San Sebastian de los Reyes", 
                        "country": "Spain", 
                        "state": "Madrid", 
                        "zip": "28702"
                    }, 
                    "name": "Hospital Infanta Sof\u00eda"
                }, 
                "investigator": {
                    "last_name": "Mar\u00eda Rosario Guiti\u00e9rrez Labrador, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "dgutierrezcastillo@gmail.com", 
                    "last_name": "Daniel Guti\u00e9rrez Castillo, MD", 
                    "phone": "0034951033931"
                }, 
                "facility": {
                    "address": {
                        "city": "C\u00e1rtama", 
                        "country": "Spain", 
                        "state": "M\u00e1laga", 
                        "zip": "29580"
                    }, 
                    "name": "Mental Health Unit Valle del Guadalhorce"
                }, 
                "investigator": {
                    "last_name": "Daniel Guti\u00e9rrez Castillo, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "maribelosunac@hotmail.com", 
                    "last_name": "Mar\u00eda Isabel Osuna Carmona, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Fuengir\u00f3la", 
                        "country": "Spain", 
                        "state": "M\u00e1laga", 
                        "zip": "29650"
                    }, 
                    "name": "Mental Health Unit Las Lagunas"
                }, 
                "investigator": {
                    "last_name": "Mar\u00eda Isabel Osuna Carmona, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "nacho.mata70@gmail.com", 
                    "last_name": "Ignacio Mata Pastor, MD, PhD", 
                    "phone": "0034948266650"
                }, 
                "facility": {
                    "address": {
                        "city": "Pamplona", 
                        "country": "Spain", 
                        "state": "Navarra", 
                        "zip": "31007"
                    }, 
                    "name": "Fundaci\u00f3n Argibide"
                }, 
                "investigator": {
                    "last_name": "Ignacio Mata Pastor, MD, PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "joaquinmartin@hotmail.com", 
                    "last_name": "Joaqu\u00edn Carlos Mart\u00edn Mu\u00f1oz, MD, PhD", 
                    "phone": "0034955016083"
                }, 
                "facility": {
                    "address": {
                        "city": "Dos Hermanas", 
                        "country": "Spain", 
                        "state": "Seville", 
                        "zip": "41700"
                    }, 
                    "name": "Hospital El Tomillar"
                }, 
                "investigator": {
                    "last_name": "Joaqu\u00edn Carlos Mart\u00edn Mu\u00f1oz, MD, PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "maria.lacruz.silvestre@gmail.com", 
                    "last_name": "Mar\u00eda Lacruz Silvestre, MD, PhD"
                }, 
                "facility": {
                    "address": {
                        "city": "Gand\u00eda", 
                        "country": "Spain", 
                        "state": "Valencia", 
                        "zip": "46700"
                    }, 
                    "name": "Hospital Francesc de Borja"
                }, 
                "investigator": {
                    "last_name": "Mar\u00eda Lacruz Silvestre, MD, PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "sonia.bustamantemadariaga@osakidetza.net", 
                    "last_name": "Sonia Bustamante Madariaga, MD, Phd", 
                    "phone": "0034944 006137"
                }, 
                "facility": {
                    "address": {
                        "city": "Bilbao", 
                        "country": "Spain", 
                        "zip": "48013"
                    }, 
                    "name": "Hospital de Basurto"
                }, 
                "investigator": {
                    "last_name": "Sonia Bustamante Madariaga, MD, PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "jmolinamar@hotmail.com", 
                    "last_name": "Juan Dios Molina Mart\u00edn, MD, PhD"
                }, 
                "facility": {
                    "address": {
                        "city": "Madrid", 
                        "country": "Spain", 
                        "zip": "28049"
                    }, 
                    "name": "Lafora Hospital"
                }, 
                "investigator": {
                    "last_name": "Juan Dios Molina Mart\u00edn, MD, PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "hergoico@gmail.com", 
                    "last_name": "Mariano Hern\u00e1ndez Monsalve, MD, PhD", 
                    "phone": "0034915347363"
                }, 
                "contact_backup": {
                    "email": "ruthberdun@yahoo.es", 
                    "last_name": "Ruth Berd\u00fan Pe, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Madrid", 
                        "country": "Spain", 
                        "zip": "28003"
                    }, 
                    "name": "Mental Health Unit Tetu\u00e1n"
                }, 
                "investigator": {
                    "last_name": "Mariano Hern\u00e1ndez Monsalve, MD, PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "fermin.mayoral.sspa@juntadeandalucia.es", 
                    "last_name": "Ferm\u00edn Mayoral Cler\u00edes, Md, PhD"
                }, 
                "facility": {
                    "address": {
                        "city": "M\u00e1laga", 
                        "country": "Spain", 
                        "zip": "29009"
                    }, 
                    "name": "Hospital Carlos Haya"
                }, 
                "investigator": {
                    "last_name": "Ferm\u00edn Mayoral Cler\u00edes, MD, PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "claram.rosso.sspa@juntadeandalucia.es", 
                    "last_name": "Clara M. Rosso Fern\u00e1ndez, MD", 
                    "phone": "0034955013414"
                }, 
                "contact_backup": {
                    "email": "mruizveguilla@yahoo.com", 
                    "last_name": "Miguel Ruiz Veguilla, MD, PhD", 
                    "phone": "0034955013414"
                }, 
                "facility": {
                    "address": {
                        "city": "Seville", 
                        "country": "Spain", 
                        "zip": "41013"
                    }, 
                    "name": "Virgen del Roc\u00edo Hospital"
                }, 
                "investigator": {
                    "last_name": "Miguel Ruiz Veguilla, MD, PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "Spain"
        }, 
        "number_of_arms": "2", 
        "official_title": "Randomized Multicentric Open-label Phase III Clinical Trial to Evaluate the Efficacy of Continual Treatment Versus Discontinuation Based in the Presence of Prodromes in a First Episode of Non-affective Psychosis.", 
        "overall_contact": {
            "email": "claram.rosso.sspa@juntadeandalucia.es", 
            "last_name": "Clara M. Rosso Fern\u00e1ndez, MD", 
            "phone": "0034955013414"
        }, 
        "overall_contact_backup": {
            "email": "mruizveguilla@yahoo.com", 
            "last_name": "Miguel Ruiz Veguilla, MD, PhD", 
            "phone": "0034955013414"
        }, 
        "overall_official": {
            "affiliation": "Virgen del Roc\u00edo Hospital", 
            "last_name": "Miguel Ruiz Veguilla, MD, PhD", 
            "role": "Study Chair"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Spain: Spanish Agency of Medicines", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "November 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The purpose of this study is to assess if patients who continue with antipsychotic treatment for 12 or more months show the same risk of relapse (measured by PANSS) that patients with the same medical condition who have followed a discontinuation treatment scheme based in the presence of prodromes.", 
            "measure": "Risk of relapse", 
            "safety_issue": "Yes", 
            "time_frame": "12 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01765829"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Fundaci\u00f3n P\u00fablica Andaluza Progreso y Salud", 
        "sponsors": {
            "collaborator": {
                "agency": "Instituto de Salud Carlos III", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Fundaci\u00f3n P\u00fablica Andaluza Progreso y Salud", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2012", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2013"
    }
}